Research location

Merritt Island

Florida, United States

Published trials50

Site observations50

Linked trials published50

Page1 / 1

Research activity in Merritt Island

Florida, United States

CureCurrent currently publishes aggregate city-level research activity for this location: 50 trials and 50 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Merritt Island

50 linked trials · page 1 of 1

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).NCT07602582 · 2026-05-22 · 1 site observation

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's DiseaseNCT06976216 · 2025-07-14 · 1 site observation

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)NCT07011732 · 2025-07-10 · 1 site observation

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADNCT06709014 · 2025-02-04 · 1 site observation

ACTIVE_NOT_RECRUITING

A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)NCT06653153 · 2024-10-24 · 1 site observation

ACTIVE_NOT_RECRUITING

A Study of Mevidalen (LY3154207) in Participants With Alzheimer's DiseaseNCT06538116 · 2024-08-26 · 1 site observation

A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's DiseaseNCT06544616 · 2024-07-22 · 1 site observation

ACTIVE_NOT_RECRUITING

Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's DiseaseNCT06268886 · 2024-03-20 · 1 site observation

ACTIVE_NOT_RECRUITING

A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate ADNCT05686044 · 2023-04-01 · 1 site observation

Open-label Extension for Phase 3 Clinical Trials of SimufilamNCT05575076 · 2022-11-07 · 1 site observation

A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's DiseaseNCT05291234 · 2022-08-15 · 1 site observation

A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)NCT05463731 · 2022-08-01 · 1 site observation

Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)NCT05364307 · 2022-06-13 · 1 site observation

A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)NCT05108922 · 2021-11-16 · 1 site observation

Simufilam 100 mg for Mild-to-Moderate Alzheimer's DiseaseNCT04994483 · 2021-11-03 · 1 site observation

A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's DiseaseNCT05063539 · 2021-09-16 · 1 site observation

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)NCT05026866 · 2021-08-27 · 1 site observation

ACTIVE_NOT_RECRUITING

A Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseNCT04619420 · 2021-01-06 · 1 site observation

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)NCT04640077 · 2020-11-23 · 1 site observation

A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's DiseaseNCT04520412 · 2020-10-27 · 1 site observation

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)NCT04437511 · 2020-06-19 · 1 site observation

ACTIVE_NOT_RECRUITING

Outcomes Mandate National Integration With Cannabis as MedicineNCT03944447 · 2018-12-01 · 1 site observation

A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)NCT03367403 · 2017-12-18 · 1 site observation

Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label TreatmentNCT03446001 · 2017-12-01 · 1 site observation

A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseNCT03131453 · 2017-08-03 · 1 site observation

Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research TrialsNCT02918539 · 2016-10-01 · 1 site observation

A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease DementiaNCT02783573 · 2016-07-01 · 1 site observation

A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)NCT02727660 · 2016-04-29 · 1 site observation

A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).NCT02670083 · 2016-03-22 · 1 site observation

A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseNCT02565511 · 2015-11-30 · 1 site observation

18F-AV-1451 Autopsy StudyNCT02516046 · 2015-09-01 · 1 site observation

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer DiseaseNCT02284906 · 2015-02-12 · 1 site observation

A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its OnsetNCT01931566 · 2013-08-01 · 1 site observation

Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionNCT00649389 · 2008-05-01 · 1 site observation

Post-PMA Approval Study: 10 Year Follow-Up IDE SubjectsNCT00721994 · 2008-05-01 · 1 site observation

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib AloneNCT00457392 · 2007-07-01 · 1 site observation

Study of Rivoglitazone in Type 2 Diabetes MellitusNCT00484198 · 2007-04-23 · 1 site observation

Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes MellitusNCT00760344 · 2007-03-01 · 1 site observation

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain MetastasesNCT00372775 · 2007-03-01 · 1 site observation

Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 DiabetesNCT00427154 · 2007-01-10 · 1 site observation

Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 1 site observation

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular SafetyNCT00359801 · 2006-07-01 · 1 site observation

Safety and Efficacy of Inhaled Insulin in Type 1 DiabetesNCT00322257 · 2006-05-01 · 1 site observation

A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)NCT00300885 · 2006-02-01 · 1 site observation

Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLCNCT00313768 · 2005-12-01 · 1 site observation

Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe HypertensionNCT00185133 · 2005-05-01 · 1 site observation

Implantable Systems Performance RegistryNCT00959296 · 2003-08-01 · 1 site observation

Warfarin and Antiplatelet Therapy in Chronic Heart FailureNCT00007683 · 1998-10-01 · 1 site observation

Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT00080340 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.